A collection of hands that take the reader through a year at the author's (fictional) bridge club. The characters make all the common errors, so the author manages to instruct while he entertains. For fans of Stewart's enormously popular syndicated bridge column, in which these characters appear regularly.
FRANK WORTHEN HAS BEEN CALLED MANY THINGS IN HIS LIFE BEGINNING WITH THE WORD QUEER Homosexuality is a divisive issue today. Many see it as a war between Christians and gays, but what if a Christian has same-sex attractions or conversely, if a gay person is also a Christian? There is likely to be a deep conflict between their faith and their desires. It is a strange and twisted world, a doctor can perform a ghoulish operation to make a man in to a woman and the world applauds his work while the new transsexual now is entitled to government aid to settle into a happy and secure life. Conversely, a gay man who receives help from a therapist to change from gay to straight is considered a traitor to the gay cause and the therapist finds himself subject to disbarment and possible criminal charges. Can gays change? Should they be allowed to change? Are ex-gays the only people group denied free choice? Find the truth for yourself. Read this book, but be forewarned it contains some raunchy episodes and is definitely NOT for children.
"Dale brings us the stories behind each bridge, covering design, engineering, ownership, finances, and politics. He chronicles the life of each, from the original construction, through modifications, and sometimes, through the bridges' multiple destructions and reconstructions... Dozens of rare photos give readers a captivating window back into the past"--from back cover.
"This guide focuses on the fighting at the bridge in Arnhem itself and the approaches to it ... [It] is designed to offer, as necessary background information, an overview of why the battle took place and an outline of the main events. That done, it then sets out to guide the visitor on a tour of the particular action at the Arnhem Bridge and the battles in Arnhem covering some of the key sights and occurrences"--Preface.
The best-selling author of Nixonland presents a portrait of the United States during the turbulent political and economic upheavals of the 1970s, covering events ranging from the Arab oil embargo and the era of Patty Hearst to the collapse of the South Vietnamese government and the rise of Ronald Reagan--Publisher's description.
Sm. thick 4to. Original illustrated cloth. Top edge gilt other edges uncut. With coloured frontpiece, 35 full-page coloured plates, and numerous text drawings. Title page printed in re/black ink.
This book is designed to give a comprehensive and systematic view of the rules for defense. The various subjects contain rules for how to defend against a long suit, when and how to ruff, how to defend against a squeeze play or an endplay, when and how to duck, when to play second hand high or third hand low, how to play from E, when to underlead your ace, how to discard and to deceive, how to defend against a Notrump contract, how to signal, and how to lead. Under each subject, there are numerous examples of how to handle each rule of defense.
Michael Steinberg's 1996 volume The Symphony: A Reader's Guide received glowing reviews across America. It was hailed as "wonderfully clear...recommended warmly to music lovers on all levels" (Washington Post), "informed and thoughtful" (Chicago Tribune), and "composed by a master stylist" (San Francisco Chronicle). Seiji Ozawa wrote that "his beautiful and effortless prose speaks from the heart." Michael Tilson Thomas called The Symphony "an essential book for any concertgoer." Now comes the companion volume--The Concerto: A Listener's Guide. In this marvelous book, Steinberg discusses over 120 works, ranging from Johann Sebastian Bach in the 1720s to John Adams in 1994. Readers will find here the heart of the standard repertory, among them Bach's Brandenburg Concertos, eighteen of Mozart's piano concertos, all the concertos of Beethoven and Brahms, and major works by Mendelssohn, Schumann, Liszt, Bruch, Dvora'k, Tchaikovsky, Grieg, Elgar, Sibelius, Strauss, and Rachmaninoff. The book also provides luminous introductions to the achievement of twentieth-century masters such as Arnold Schoenberg, Be'la Barto'k, Igor Stravinsky, Alban Berg, Paul Hindemith, Sergei Prokofiev, Aaron Copland, and Elliott Carter. Steinberg examines the work of these musical giants with unflagging enthusiasm and bright style. He is a master of capturing the expressive, dramatic, and emotional values of the music and of conveying the historical and personal context in which these wondrous works were composed. His writing blends impeccable scholarship, deeply felt love of music, and entertaining whimsy. Here then is a superb journey through one of music's richest and most diverse forms, with Michael Steinberg along as host, guide, and the best of companions.
A comprehensive primer to help non-experts evaluate clinical studies of new therapies. If you work in or around biotech, you're supposed to understand clinical trial results. But what if you're not an expert in study design or biostatistics? You may feel out of your comfort zone when faced with a journal article, press release, or investor presentation. Inside this book: -- Structured roadmap for assessing the main components of a planned orcompleted biotech trial.-- Clear explanations of the most common concepts and terms in biotechclinical studies, illustrated with over 100 real-world examples.-- Deep dives on essential topics like p values, sample size calculations, andKaplan-Meier curves, written in plain English for non-statisticians.-- Pointers for interpreting positive and negative study results, understandingcommon figures and tables, and identifying red flags in press releases.If you're a biotech executive, investor, advisor, or entrepreneur--or aspire to be one--this handbook will give you the foundation you need to analyze planned and completed clinical trials with more confidence."Hugely helpful. I wish I'd had a book like this earlier in my career." - SIR MENEPANGALOS, Executive VP, Biopharmaceuticals R&D, AstraZeneca"A terrific primer for non-experts looking to better evaluate new therapies." -DAPHNE ZOHAR, Founder and CEO, PureTech Health"Crisp and clear. Wise advice on when to rely on clinical data and when to beskeptical." - MICHAEL ROSENBLATT, Senior Partner, Flagship Pioneering"A source of much-needed illumination." - DAN LEPANTO, Senior ManagingDirector, M&A, SVB Leerink